Back to News

GVK Biosciences Renews AAALAC International Accreditation in Animal Care

August 23, 2016

Hyderabad India — August 23, 2016 — GVK Biosciences is pleased to announce that the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International has granted extension of FULL ACCREDITATION for its animal care and use programs. The animal facility was first awarded the AAALAC International accreditation in July, 2010 and the same has now been renewed.

The AAALAC International Council on Accreditation conducted an extensive on-site assessment and review of the GVK BIO animal care and use program. The Council commended GVK BIO and the staff for providing and maintaining quality program laboratory animal care and use. The Council especially cited the excellent husbandry, evidenced in part by the clean cages with healthy animals, the dedicated and knowledgeable attending Veterinarian and the well trained and committed veterinary staff.

“We are proud that AAALAC has granted GVK BIO continuation of Full Accreditation. The accreditation demonstrates GVK BIO’s commitment to high standards of animal care and compliance with industry and regulatory guidelines,” commented Dr. Lakshman Rajagopalan, Senior Vice President, Biology services at GVK BIO

AAALAC International is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs.
More than 950 companies, universities, hospitals, government agencies and other research institutions in 41 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use. These institutions volunteer to participate in AAALAC’s program, in addition to complying with the local, state and federal laws that regulate animal research.

GVK Biosciences (GVK BIO) is one of  Asia’s leading Discovery Research and Development organization. GVK BIO provides a broad spectrum of services across the R&D and manufacturing value chain that include Discovery, Integrated Programs, Process R&D, Chemical Development, Analytical Development, Formulations R&D, Biologics Services, Contract Manufacturing and Drug Repurposing.
GVK BIO’s diverse portfolio of more than 350 customers include some of the world’s largest pharmaceutical, biotechnology, agro, life science companies and leading academic institutions.